Biomedical Technology

Nordia Biotech & Pharmaceuticals HK Limited

🌍 Official Website 🏢 HKSTP Source
55 Potential

Decision Maker

N/A
enquiry.marketing@hkstp.org
+852 2629 1818
5/F, Building 5E, 5 Science Park East Avenue, Hong Kong Science Park
Raw Description
No Diabetes & Restore health | Description | Nordia Biotech & Pharmaceuticals is a spin-off company from LKS Faculty of Medicine, HKU. It was founded in December 2023 by Prof ZHOU Zhongjun, the Chui Fook-Chuen Endowed Professor from HKUMed with over 30 years of experience in development, ageing and age-associated diseases, together with his former PhD student, HE Yi, who developed the core technology. Our team members are very experienced in investment, financing, transformation and operation. Nordia Biotech finished its HKD 7M Series Angel led by HKX, and started the HKD 30M Pre-A. We received the financial support from TSSSU+ and Incu-Bio already. | Nordia Biotech targets the unmet medical needs, specifically diabetes mellitus, with functional islet organoids generated from stem cells through a self-developed, unique patented method enabling spontaneous formation of a 3D structure of islets. The islet organoids will be transplanted into the anterior sheath of the rectus abdominis muscle of patients, for long-term control of blood glucose levels by steady insulin secretion. Other products include biomaterial scaffolds to encapsulate islet organoids to increase the transplantation efficiency. The company offers islet-based contract research services, islet products as well. || Product | biomaterial for transplantation | Technology | Invention/Technology Highlights: 1. We have established a disruptive production method for the spontaneous formation of 3D structures of islet organoids with independent IP rights, which is globally leading; 2. We have developed a new type of biocompatible and highly effective co-transplantation biomaterials that can enhance the survival rate of transplanted tissues; 3. We are currently developing a universal pancreatic islet organoid applicable to all patients.

Strategic Analysis

Executive Brief

Nordia Biotech is a clinical-stage HKU spin-off specializing in regenerative medicine for Type 1 and Type 2 Diabetes. Their core innovation involves the spontaneous 3D formation of islet organoids from stem cells and the development of specialized biomaterial scaffolds for transplantation into the rectus abdominis. They operate at the intersection of stem cell biology, tissue engineering, and implantable medical devices.

Strategic Fit & Lead Score

Lead Score: 55 (Possible Consulting / Custom R&D)

Why this Score? While Nordia is primarily a biotech firm, their "unmet medical need" involves long-term implantable scaffolds and precise glucose monitoring. 6C's MPCVD diamond technology offers two critical advantages for their roadmap:

  1. Biocompatibility: Diamond is the most chemically inert and biocompatible material for long-term implants, potentially outperforming their current "new type" of biomaterials in reducing immune rejection.
  2. Sensing: Their islet products require precise glucose monitoring. Boron-Doped Diamond (BDD) is the premier material for electrochemical biosensors due to its wide potential window and resistance to bio-fouling.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
Glucose Monitoring Boron-Doped Diamond (BDD) Electrodes BDD provides a wide electrochemical potential window and low background current for high-sensitivity, non-fouling glucose sensing in culture or in vivo.
Implant Longevity Nanocrystalline Diamond (NCD) Coating Coating their "biomaterial scaffolds" with ultra-thin NCD provides a chemically inert barrier, reducing fibrous encapsulation and inflammatory responses from the host.
Cell Culture Substrates SCD/PCD Plates (Ra < 1nm) Diamond's surface energy and protein adsorption properties can be tuned (H-terminated vs O-terminated) to enhance islet organoid attachment and 3D morphology during growth.
Lab-Grade Water BDD Electrochemical Oxidation For their "Incu-Bio" and lab operations: BDD electrodes generate hydroxyl radicals for chemical-free, high-purity sterilization of water used in stem cell media preparation.

Engagement Hooks

  • Technical Question: "Have you evaluated the impact of surface-energy-tuned scaffolds on the spontaneous 3D formation rate of your islet organoids, or encountered limitations with bio-fouling in your glucose monitoring assays?"
  • Value Statement: "6C can provide medical-grade MPCVD diamond coatings and BDD sensing elements to ensure Nordia's islet scaffolds achieve maximum biocompatibility and lifetime stability within the rectus abdominis muscle."